A generalist vision-language foundation model for diverse biomedical tasks.
Kai ZhangRong ZhouEashan AdhikarlaZhiling YanYixin LiuJun YuZhengliang LiuXun ChenBrian D DavisonHui RenJing HuangChen ChenYuyin ZhouSunyang FuWei LiuTianming LiuXiang LiYong ChenLifang HeJames Y ZouQuanzheng LiHongfang LiuLichao SunPublished in: Nature medicine (2024)
Traditional biomedical artificial intelligence (AI) models, designed for specific tasks or modalities, often exhibit limited flexibility in real-world deployment and struggle to utilize holistic information. Generalist AI holds the potential to address these limitations due to its versatility in interpreting different data types and generating tailored outputs for diverse needs. However, existing biomedical generalist AI solutions are typically heavyweight and closed source to researchers, practitioners and patients. Here, we describe BiomedGPT, the first open-source and lightweight vision-language foundation model, designed as a generalist capable of performing various biomedical tasks. BiomedGPT achieved state-of-the-art results in 16 out of 25 experiments while maintaining a computing-friendly model scale. We also conducted human evaluations to assess the capabilities of BiomedGPT in radiology visual question answering, report generation and summarization. BiomedGPT exhibits robust prediction ability with a low error rate of 3.8% in question answering, satisfactory performance with an error rate of 8.3% in writing complex radiology reports, and competitive summarization ability with a nearly equivalent preference score to human experts. Our method demonstrates that effective training with diverse data can lead to more practical biomedical AI for improving diagnosis and workflow efficiency.
Keyphrases
- artificial intelligence
- big data
- machine learning
- deep learning
- endothelial cells
- working memory
- electronic health record
- end stage renal disease
- autism spectrum disorder
- chronic kidney disease
- ejection fraction
- newly diagnosed
- primary care
- pluripotent stem cells
- induced pluripotent stem cells
- emergency department
- prognostic factors
- patient reported outcomes
- adverse drug
- general practice
- low cost